CNSP
Cns Pharmaceuticals Inc

7,739
Mkt Cap
$3.85M
Volume
42,189.00
52W High
$114.00
52W Low
$4.93
PE Ratio
-0.11
CNSP Fundamentals
Price
$6.20
Prev Close
$6.23
Open
$6.15
50D MA
$7.25
Beta
0.98
Avg. Volume
14,412.53
EPS (Annual)
-$466.44
P/B
0.36
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved
The company intends to commence the phase 2 study of its lead program, TPI 287, to treat Glioblastoma Multiforme (GBM) by year-end.
Stocktwits·7mo ago
<
...
1
>

Latest CNSP News

View

Advertisement|Remove ads.

Advertisement|Remove ads.